Carl Zeiss Meditec AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CZMWY research report →
About the company
Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures.
- CEO
- Andreas Pecher
- IPO
- 2012
- Employees
- 2,066
- HQ
- Jena, DE
Price Chart
- Market Cap
- $2.77B
- P/E
- 27.97
- P/S
- 0.95
- P/B
- 1.20
- EV/EBITDA
- 10.24
- Div Yield
- 1.91%
- Gross Margin
- 50.81%
- Op Margin
- 6.15%
- Net Margin
- 3.41%
- ROE
- 4.29%
- ROIC
- 4.08%
- Revenue
- $2.23B · 7.82%
- Net Income
- $141.21M · -20.99%
- EPS
- $1.52 · -24.38%
- Op Income
- $223.32M
- FCF YoY
- 97.86%
- 52W High
- $62.08
- 52W Low
- $26.65
- 50D MA
- $30.36
- 200D MA
- $39.05
- Beta
- 1.33
- Avg Volume
- 4.31K
Get TickerSpark's AI analysis on CZMWY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CZMWY coverage
Recent articles, reports, and earnings notes.
No research on CZMWY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CZMWY report →Similar companies
Peers in the same neighborhood.